Stanford researchers have developed a system that assesses altered mental states in both human and animal subjects using neural biomarkers, allowing for repeatable cross-species studies of potential treatments for psychiatric and neurological disorders.
Researchers at Stanford developed a novel technique to induce persistent mixed hematopoietic cell chimerism in organ recipients to protect against organ graft rejection and increase immune tolerance.
Stanford researchers Robert Lowsky and Samuel Strober have developed a strategy for maintaining normal graft function without immune suppression medication. Kidney transplant recipients require lifelong use of immunosuppressants to minimize rejection risk.
Researchers at Stanford have developed methods and compositions to provide inducible production of anti-inflammatory cytokines in mesenchymal stem cells (MSCs).
Stanford scientists have developed a plant-derived zinc protoporphyrin (ZnPP) produced from legume hemoglobin, a breakthrough therapy candidate for treating neonatal jaundice.
Stanford researchers have developed a novel blood-based diagnostic platform that leverages circulating bacteriophage DNA (phage cfDNA) to enable sensitive and highly specific detection of both overt and subclinical bacterial infections, while effectively discriminating them fr
Stanford researchers have developed a novel technology using extracellular vesicles (EVs) to selectively suppress immune responses to AAV vectors, enabling safer and more effective gene therapy.
Researchers in Dr. Mark Kay's lab have developed a method for site-specific gene targeting that does not require nucleases. Gene therapy attempts to cure disease by manipulating the genetic material which holds the instructions for the function of our cells and our bodies.
Researchers in the Wyss-Coray Lab are investigating a potential therapeutic antibody to treat lysosomal storage disorders and other related neurodegenerative diseases.
Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.